의료용 근적외선 이미징 시장 : 제품별, 기술별, 모달리티별, 용도별, 최종 사용자별, 유통 채널별 - 세계 시장 예측(2026-2032년)

The Near Infrared Imaging in Healthcare Market is projected to grow by USD 2.96 billion at a CAGR of 5.58% by 2032.

Near infrared imaging in healthcare is advancing from a specialized visualization tool to a core enabling technology for precision diagnostics, image-guided surgery, vascular assessment, oncology workflows, wound care, and point-of-care monitoring. Operating primarily across the 700-2,500 nm spectrum, near infrared imaging supports deeper tissue penetration than visible light while reducing tissue autofluorescence, making it valuable for real-time clinical decision-making in procedures where perfusion, lymphatic mapping, tumor margins, and vascular integrity influence outcomes.

Momentum is supported by established clinical use of indocyanine green (ICG), fluorescence-guided surgery platforms, ophthalmic angiography systems, hyperspectral imaging, and emerging wearable or portable NIR devices. Demand is strongest where healthcare systems are prioritizing minimally invasive procedures, lower complication risks, improved perfusion assessment, faster intraoperative confirmation, and objective visualization that complements ultrasound, computed tomography, magnetic resonance imaging, and conventional endoscopy.

Transformative Shifts in the Near Infrared Imaging Landscape

The near infrared imaging landscape is being reshaped by the transition from standalone visualization to integrated clinical intelligence. Surgical suites increasingly combine NIR fluorescence with robotic platforms, endoscopy systems, laparoscopic towers, and digital operating room infrastructure to support immediate interpretation during complex procedures, including colorectal surgery, hepatobiliary procedures, reconstructive surgery, sentinel lymph node mapping, and vascular assessment.

Another major shift is the expansion of NIR imaging beyond tertiary hospitals. Portable devices, improved camera sensitivity, compact light sources, standardized fluorophore protocols, and cloud-connected software are enabling broader use in wound assessment, vascular access, flap monitoring, ambulatory surgery, and bedside care. These shifts favor developers and healthcare providers that can prove clinical utility, workflow efficiency, regulatory compliance, infection-control suitability, and interoperability with hospital information systems.

Cumulative Impact of Artificial Intelligence on NIR Imaging

Artificial intelligence is increasing the value of near infrared imaging by improving image segmentation, perfusion quantification, tissue classification, motion correction, signal normalization, and anomaly detection. In applications such as fluorescence-guided surgery, ophthalmic angiography, and wound imaging, AI can help standardize interpretation where visual assessment alone may vary by operator experience, camera settings, dye timing, or patient-specific physiology.

The cumulative impact of AI is also commercial and regulatory. Manufacturers are moving toward software-enabled platforms that support decision support, longitudinal monitoring, automated reporting, and integration with digital surgical records. However, adoption depends on validated datasets, transparent model performance, bias management, cybersecurity controls, post-market monitoring, and alignment with medical device software regulations, including FDA guidance for software as a medical device and evolving European AI and medical device requirements.

Key Regional Insights for Near Infrared Imaging Adoption

North America remains a leading region for near infrared imaging in healthcare due to mature hospital infrastructure, high surgical procedure volumes, strong medical device innovation, and established regulatory pathways for imaging systems, contrast agents, and software-enabled medical technologies. Europe shows steady adoption through academic hospitals, cancer centers, and minimally invasive surgery programs, although implementation is influenced by the EU Medical Device Regulation, national procurement cycles, evidence standards, and health technology assessment expectations.

Asia-Pacific is gaining momentum through hospital expansion in China and India, advanced optics and device engineering capabilities in Japan and South Korea, and rising demand for minimally invasive care across major urban health systems. Latin America is building adoption through private hospitals and specialty surgical centers in Brazil and Mexico, where advanced imaging is increasingly linked to oncology, reconstructive surgery, and vascular care. The Middle East is investing in advanced surgical infrastructure through health system modernization programs, with premium hospitals prioritizing robotic surgery, oncology services, and high-acuity care. Africa remains earlier-stage, with opportunity concentrated in referral hospitals, teaching institutions, donor-supported surgical capacity, and portable imaging models suited to constrained infrastructure.

Key Group Insights Across ASEAN, GCC, EU, BRICS, G7, and NATO

Within ASEAN, rising healthcare investment, medical tourism, private hospital expansion, and government-backed digital health initiatives are supporting demand for near infrared imaging in surgical and diagnostic settings, particularly in Singapore, Thailand, Malaysia, Indonesia, Vietnam, and the Philippines. GCC countries are deploying premium hospital technologies as part of national health transformation strategies, with adoption linked to oncology, cardiovascular care, transplant services, robotic surgery, and efforts to reduce outbound medical travel.

The European Union is defined by stringent regulatory requirements, strong clinical research networks, cross-border scientific collaboration, and structured evidence expectations that influence adoption of NIR imaging platforms and AI-enabled software. BRICS markets combine large patient populations with uneven but expanding access to advanced imaging, supported by hospital construction, domestic manufacturing policies, and high demand for cost-effective diagnostic and surgical technologies. G7 countries remain central to innovation, reimbursement evidence, clinical guideline development, and device commercialization, while NATO-aligned markets benefit from resilient medical supply chains, cybersecurity priorities, and high standards for hospital technology procurement, especially where connected imaging platforms are integrated into critical health infrastructure.

Key Country Insights for NIR Imaging in Healthcare

The United States leads in commercialization, clinical trials, surgeon adoption, and FDA-cleared imaging platforms, with NIR use supported by advanced operating rooms, robotic surgery programs, ophthalmology networks, and oncology centers. Canada emphasizes hospital-based adoption, evidence-driven procurement, and integration within publicly funded care pathways, while Mexico and Brazil are important Latin American markets where private healthcare systems, specialty hospitals, and urban surgical centers are accelerating access to advanced fluorescence and perfusion imaging.

In Europe, the United Kingdom, Germany, France, Italy, and Spain support adoption through academic medicine, cancer care, reconstructive surgery, vascular surgery, and minimally invasive procedure programs, with Germany and France benefiting from strong clinical research ecosystems and the United Kingdom maintaining emphasis on evidence-based implementation. Russia has selective demand in advanced urban hospitals, especially where high-acuity surgical services and oncology care are concentrated. China is scaling domestic innovation, hospital infrastructure, and high-volume surgical capacity; India is expanding access through high-throughput tertiary centers and growing private hospital networks; Japan and South Korea contribute advanced optics, sensors, miniaturized imaging systems, and medical device engineering; and Australia offers a sophisticated regulatory, hospital, and clinical research environment for premium imaging technologies.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize clinical validation, workflow integration, and evidence generation. Hospitals, surgeons, and payers increasingly require proof that near infrared imaging improves decision-making, reduces avoidable complications, supports perfusion assessment, or increases procedural confidence. Developers should invest in multicenter studies, standardized imaging protocols, surgeon education, real-world evidence programs, and peer-reviewed data that demonstrate performance across patient populations and clinical settings.

Technology providers should also strengthen AI governance, cybersecurity, usability, and interoperability. Platforms that integrate with robotic surgery systems, electronic health records, picture archiving and communication systems, structured reporting tools, and digital operating room infrastructure will be better positioned for adoption. Commercial strategies should be tailored by region, balancing premium integrated systems for advanced hospitals with portable, cost-efficient devices for emerging markets and point-of-care settings.

Research Methodology

This executive summary is developed using a structured secondary and primary research approach focused on verified healthcare, regulatory, clinical, and technology sources. Key inputs include peer-reviewed literature, clinical trial registries, regulatory databases, medical device guidance documents, public health system indicators, hospital procurement trends, patent activity, reimbursement policy references, and recognized datasets from organizations such as WHO, OECD, and the World Bank.

Findings are triangulated across device approvals, clinical adoption patterns, technology readiness, reimbursement context, regulatory requirements, and regional healthcare infrastructure. Conclusions avoid unsupported claims and prioritize evidence-backed signals, including documented NIR use cases in fluorescence-guided surgery, perfusion imaging, ophthalmology, oncology, wound care, vascular assessment, reconstructive surgery, and emerging AI-assisted image analysis.

Conclusion

Near infrared imaging in healthcare is moving into a more strategic phase as hospitals seek technologies that improve precision, safety, visualization, and procedural efficiency. The combination of fluorescence imaging, hyperspectral imaging, AI-enabled analytics, portable devices, and integrated surgical platforms is expanding the technology's relevance across operating rooms, outpatient settings, specialty clinics, and point-of-care environments.

Future leadership will depend on validated performance, usability, regulatory readiness, interoperability, cybersecurity, and scalable deployment. Organizations that align innovation with clinical evidence, regional healthcare needs, reimbursement expectations, and digital health integration will be best positioned to support long-term adoption of near infrared imaging in healthcare.

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Definition
• 1.3. Market Segmentation & Coverage
• 1.4. Years Considered for the Study
• 1.5. Currency Considered for the Study
• 1.6. Language Considered for the Study
• 1.7. Key Stakeholders

2. Research Methodology

• 2.1. Introduction
• 2.2. Research Design
  • 2.2.1. Primary Research
  • 2.2.2. Secondary Research
• 2.3. Research Framework
  • 2.3.1. Qualitative Analysis
  • 2.3.2. Quantitative Analysis
• 2.4. Market Size Estimation
  • 2.4.1. Top-Down Approach
  • 2.4.2. Bottom-Up Approach
• 2.5. Data Triangulation
• 2.6. Research Outcomes
• 2.7. Research Assumptions
• 2.8. Research Limitations

3. Executive Summary

• 3.1. Introduction
• 3.2. CXO Perspective
• 3.3. Market Size & Growth Trends
• 3.4. Market Share Analysis, 2025
• 3.5. FPNV Positioning Matrix, 2025
• 3.6. New Revenue Opportunities
• 3.7. Next-Generation Business Models
• 3.8. Industry Roadmap

4. Market Overview

• 4.1. Introduction
• 4.2. Industry Ecosystem & Value Chain Analysis
  • 4.2.1. Supply-Side Analysis
  • 4.2.2. Demand-Side Analysis
  • 4.2.3. Stakeholder Analysis
• 4.3. Market Dynamics
  • 4.3.1. Key Drivers
  • 4.3.2. Key Restraints
  • 4.3.3. Key Opportunities
  • 4.3.4. Key Challenges
• 4.4. Porter's Five Forces Analysis
• 4.5. PESTLE Analysis
• 4.6. Market Outlook
  • 4.6.1. Near-Term Market Outlook (0-2 Years)
  • 4.6.2. Medium-Term Market Outlook (3-5 Years)
  • 4.6.3. Long-Term Market Outlook (5-10 Years)
• 4.7. Go-to-Market Strategy

5. Market Insights

• 5.1. Consumer Insights & End-User Perspective
• 5.2. Consumer Experience Benchmarking
• 5.3. Opportunity Mapping
• 5.4. Distribution Channel Analysis
• 5.5. Pricing Trend Analysis
• 5.6. Regulatory Compliance & Standards Framework
• 5.7. ESG & Sustainability Analysis
• 5.8. Disruption & Risk Scenarios
• 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Near Infrared Imaging in Healthcare Market, by Offerings

• 7.1. Devices
  • 7.1.1. Filters
  • 7.1.2. Imaging Systems
  • 7.1.3. Spectrometers
• 7.2. Reagents & Kits
  • 7.2.1. Indocyanine Green (ICG)
  • 7.2.2. Methylene Blue
• 7.3. Software

8. Near Infrared Imaging in Healthcare Market, by Technology

• 8.1. Diffuse Reflectance Imaging
• 8.2. Hyperspectral Imaging
• 8.3. Multispectral Imaging

9. Near Infrared Imaging in Healthcare Market, by Modality

• 9.1. Integrated Imaging Systems
• 9.2. Standalone Imaging Systems

10. Near Infrared Imaging in Healthcare Market, by Applications

• 10.1. Cancer Surgeries
• 10.2. Cardiovascular Surgeries
• 10.3. Dermatology
• 10.4. Gastrointestinal Surgeries
• 10.5. Preclinical Imaging

11. Near Infrared Imaging in Healthcare Market, by End User

• 11.1. Hospitals & Clinics
• 11.2. Pharmaceutical & Biotechnology Companies
• 11.3. Research Laboratories

12. Near Infrared Imaging in Healthcare Market, by Distribution Channel

• 12.1. Offline
  • 12.1.1. Direct Sale
  • 12.1.2. Distributor Network
• 12.2. Online

13. Near Infrared Imaging in Healthcare Market, by Region

• 13.1. Asia-Pacific
• 13.2. North America
• 13.3. Latin America
• 13.4. Europe
• 13.5. Middle East
• 13.6. Africa

14. Near Infrared Imaging in Healthcare Market, by Group

• 14.1. ASEAN
• 14.2. GCC
• 14.3. European Union
• 14.4. BRICS
• 14.5. G7
• 14.6. NATO

15. Near Infrared Imaging in Healthcare Market, by Country

• 15.1. United States
• 15.2. Canada
• 15.3. Mexico
• 15.4. Brazil
• 15.5. United Kingdom
• 15.6. Germany
• 15.7. France
• 15.8. Russia
• 15.9. Italy
• 15.10. Spain
• 15.11. China
• 15.12. India
• 15.13. Japan
• 15.14. Australia
• 15.15. South Korea

16. Competitive Landscape

• 16.1. Market Concentration Analysis, 2025
  • 16.1.1. Concentration Ratio (CR)
  • 16.1.2. Herfindahl Hirschman Index (HHI)
• 16.2. Recent Developments & Impact Analysis, 2025
• 16.3. Product Portfolio Analysis, 2025
• 16.4. Benchmarking Analysis, 2025

17. Company Profiles

• 17.1. AAT Bioquest, Inc.
• 17.2. Biotium
• 17.3. Carl Zeiss AG
• 17.4. Cayman Chemical
• 17.5. Crysta-LYN Chemical Company
• 17.6. EXOSENS
• 17.7. Gowerlabs Ltd.
• 17.8. Hamamatsu Photonics K.K.
• 17.9. KARL STORZ SE & Co. KG
• 17.10. Leica Microsystems
• 17.11. LI-COR Biotech
• 17.12. Medtronic PLC
• 17.13. Merck KGaA
• 17.14. MIZUHO Corporation
• 17.15. Motherson Group
• 17.16. MP Biomedicals
• 17.17. NIRX Medical Technologies, LLC
• 17.18. Olympus Corporation
• 17.19. Oxford Instruments
• 17.20. Quest Medical Imaging B.V.
• 17.21. Revvity, Inc.
• 17.22. Shimadzu Corporation
• 17.23. Stryker Corporation
• 17.24. Thermo Fisher Scientific Inc.